main street development group, LLC

po box 94
newark, new york 14513

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 27, 2014

NYS DOS ID#
4599274

County
WAYNE

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - MAIN STREET DEVELOPMENT GROUP, LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Harvey Techies Pass Baton, And APIs, To Florida Peers as Irma Nears
    By Angela Shah - Friday Sep 8, 2017

    Houston—As Tropical Storm Harvey made landfall in Houston, Florida resident Leah Halbina messaged friends in the city asking how she could help. That was how she found out about Sketch City and the various civic tech projects the group and others were developing to aid rescue efforts, help people find shelter, and tend to other […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug
    By Frank Vinluan - Tuesday May 30, 2017

    Protagonist Therapeutics’ work developing an inflammatory bowel disease drug that can be taken as a pill, rather than injected, now has fresh cash and the backing of a large pharmaceutical partner. Newark, CA-based Protagonist (NASDAQ: PTGX) has entered a partnership with Janssen Biotech to develop and commercialize its drug, PTG-200. Janssen is paying Protagonist $50 […]

    Source: Xconomy New York
  • Cheddar is on a Mission to Help Software Developers Monetize Faster
    By Sarah Schmid Stevenson - Wednesday Nov 8, 2017

    It’s a tale as old as tech startups: A software developer creates a new app that she’s convinced will take the world by storm. The only problem? She has no idea how to monetize her brilliant creation. A startup based in Bloomington, IN, called Cheddar aims to solve that problem by changing the way developers […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed